Showing 3821-3830 of 8196 results for "".
- Hair & Scalp Disorders in Focus at Upcoming Virtual CME Conferencehttps://practicaldermatology.com/news/hair-scalp-disorders-in-focus-at-upcoming-virtual-cme-conference/2474649/Organizers have launched a new CME-accredited conference focused on providing dermatologists insights and strategies for treating hair and scalp disorders in diverse populations. Hair & Scalp Disorders: The Rx Pad & Be
- Dupilumab Improves Clinical and Immunologic Markers in NShttps://practicaldermatology.com/news/dupilumab-improves-clinical-and-immunologic-markers-in-ns/2474591/Results from a recent pilot study suggest an IL-4/IL-13 blockade with dupilumab significantly improved skin and immunologic abnormalities in patients with Netherton syndrome (NS).
- Market for Atopic Dermatitis Treatments to Surge Past $22 Billionhttps://practicaldermatology.com/news/market-for-atopic-dermatitis-treatments-to-surge-past-22-billion/2474524/The global atopic dermatitis (AD) market is projected to more than double over the next decade, reaching $22.37 billion by 2034, new research from Polaris Market Research indicates. Driven by an annual growth rate of 8.5%, the
- Analysis: Drug Class Influences Clinical Management of Eruptive Keratoacanthoma/Squamous Cell Carcinomahttps://practicaldermatology.com/news/drug-class-influences-clinical-profile-and-management-of-eruptive-kascc/2474440/The clinical features and management of drug-induced eruptive keratoacanthoma (KA) and squamous cell carcinoma (SCC) differ significantly depending on the causative drug class, according to a new analysis of 172 reported cases.
- Study Finds Gaps in Lichen Planus Screening and Treatment Among U.S. Dermatologistshttps://practicaldermatology.com/news/study-finds-gaps-in-lichen-planus-screening-and-treatment-among-us-dermatologists/2474421/A new cross-sectional study from George Washington University shows significant variability in how U.S. dermatologists diagnose and manage lichen planus, according to a news release. Surveying over 400 board-certified dermatol
- From ASLMS: Advances in Infantile Hemangioma Diagnosis and Carehttps://practicaldermatology.com/news/from-aslms-advances-in-infantile-hemangioma-diagnosis-and-care/2474328/New guidelines from the International Society for the Study of Vascular Anomalies (ISSVA) offer more precise classification and improved multidisciplinary pathways for patient care. Kristen Kelly, MD, Professor of Dermatology and Surgery a
- Ivarmacitinib Demonstrates Efficacy in Phase 3 Trial for Atopic Dermatitishttps://practicaldermatology.com/news/ivarmacitinib-demonstrates-efficacy-in-phase-3-trial-for-atopic-dermatitis/2474409/A new Phase 3 randomized clinical trial shows that ivarmacitinib, an oral JAK1 inhibitor, significantly improves clinical signs of moderate to severe atopic dermatitis (AD) in both adolescents and adults with a favorable safety profile.
- FDA Gives Nod to First Cell-Based Gene Therapy for Recessive Dystrophic Epidermolysis Bullosahttps://practicaldermatology.com/news/fda-gives-nod-to-first-cell-based-gene-therapy-for-recessive-dystrophic-epidermolysis-bullosa/2474382/The U.S. Food and Drug Administration (FDA) has approved ZEVASKYN (prademagene zamikeracel, pz-cel), making it the first cell-based gene therapy for the treatment of wounds in patients with recessive dystrophic epidermolysis bullosa (RDEB). The approval addresses a major unmet clinical nee
- From ASLMS 2025: Dr. Joel Cohen Highlights New Fractional Laser Techniques, Including Laser-enabled Tissue Coringhttps://practicaldermatology.com/news/from-aslms-dr-joel-cohen-highlights-new-fractional-laser-techniques-for-scars-at-aslms/2474327/During a fractional laser section of the recent program of the 2025 American Society for Laser Medicine and Surgery (ASLMS) Annual Meeting in Orlando, board-certified dermatologist, Mohs surgeon, and laser expert Joel L. Cohen, MD, FAAD, FACMS, presented clinical insights into fractional laser us
- Candela Launches Dual-Wavelength Vbeam Pro for Vascular and Dermatologic Conditionshttps://practicaldermatology.com/news/candela-launches-dual-wavelength-vbeam-pro-for-vascular-and-dermatologic-conditions/2474321/Candela has introduced its latest pulsed dye laser platform, the Vbeam Pro, at the 2025 Annual Meeting of the American Society for Laser Medicine and Surgery (ASLMS) in Orlando, Florida.